Gilead set­tles with Mary­land dis­trib­u­tor over al­leged coun­ter­feit HIV drugs

Gilead’s years­long le­gal bat­tle against what it said was a traf­fick­er of coun­ter­feit HIV med­i­cines is com­ing to a close.

The phar­ma com­pa­ny struck a set­tle­ment deal with Mary­land-based phar­ma­ceu­ti­cal dis­trib­u­tor Safe Chain So­lu­tions and its own­ers Patrick and Charles Boyd on Tues­day, bar­ring them from sell­ing Gilead prod­ucts. Lit­i­ga­tion against dozens of oth­er de­fen­dants is on­go­ing.

Gilead filed suit against Safe Chain in 2021 af­ter re­ceiv­ing com­plaints from pa­tients about “au­then­tic-look­ing” bot­tles of Gilead HIV meds that were filled with the wrong drug. In some cas­es, Gilead said the bot­tles con­tained high-dose tablets of an an­tipsy­chot­ic called que­ti­ap­ine, com­mon­ly sold un­der the brand name Sero­quel.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER